Ovarian Cancer | Specialty

The OncLive Ovarian Cancer condition center page is a comprehensive resource for clinical news and expert insights on ovarian cancer and evolving treatment approaches, including PARP inhibitors, antibody-drug conjugates, chemotherapy and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in ovarian cancer.

Challenges for the Future of Gynecologic Cancers

November 26th 2014

Emerging Therapies in Cervical Cancer

November 26th 2014

Bevacizumab in Recurrent Metastatic Cervical Cancer

November 26th 2014

Cervical Cancer Screening and Prevention

November 26th 2014

Promising Treatments in Ovarian Cancer

November 26th 2014

Bevacizumab in Ovarian Cancer

November 26th 2014

Platinum Resistance in Ovarian Cancer

November 26th 2014

CA-125 Testing in Ovarian Cancer

November 26th 2014

Intraperitoneal Chemotherapy in Ovarian Cancer

November 26th 2014

Antiangiogenic Agents in Ovarian Cancer

November 26th 2014

Treatment Options in Ovarian Cancer

November 26th 2014

Chemotherapy Regimens for Ovarian Cancer

November 26th 2014

Goal of Surgery in Ovarian Cancer

November 26th 2014

Cytoreductive Surgery for Ovarian Cancer

November 26th 2014

Neoadjuvant Chemotherapy for Ovarian Cancer

November 26th 2014

Timing of Oophorectomy in Ovarian Cancer

November 26th 2014

Prophylactic Oophorectomy for Reducing Ovarian Cancer Risk

November 26th 2014

Universal Screening for BRCA1 and BRCA2 Mutations

November 26th 2014

Dr. Wright Discusses the Molecular Biology of Ovarian Cancer

November 25th 2014

Jason D. Wright, MD, Division Chief, Gynecologic Oncology, Associate Clinical Professor of Gynecologic Oncology, Sol Goldman Associate Professor of Obstetrics and Gynecology, Columbia University, discusses the molecular biology of ovarian cancer.

Pre-Chemo Abiraterone Extends Survival in CRPC

November 21st 2014

x